Señales en vivo de 001065.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 20:00):

JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others...

Stats
Volumen de hoy	8.00
Volumen promedio	230.00
Capitalización de mercado	714.61B
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW0 (0.00%)

JW Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JW Pharmaceutical Finanzas

Annual	2023
Ingresos:	KRW748.53B
Beneficio Bruto:	KRW335.67B (44.84 %)
EPS:	KRW1 503.91

FY	2023
Ingresos:	KRW748.53B
Beneficio Bruto:	KRW335.67B (44.84 %)
EPS:	KRW1 503.91

FY	2022
Ingresos:	KRW684.35B
Beneficio Bruto:	KRW287.95B (42.08 %)
EPS:	KRW1 267.10

FY	2021
Ingresos:	KRW606.58B
Beneficio Bruto:	KRW234.38B (38.64 %)
EPS:	KRW-9.23

Financial Reports:

No articles found.

JW Pharmaceutical